Hidden breast cancer subtype revealed in egyptian patients
NCT ID NCT06188494
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This study reviewed medical records of 405 adults in Egypt with advanced HER2-negative breast cancer to find out how many actually have a subtype called HER2-low. Researchers looked at past test results to count cases and describe patient characteristics. The goal was to better understand this group, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alexandria, Egypt
-
Research Site
Asyut, Egypt
-
Research Site
Cairo, Egypt
-
Research Site
Gharbia, Egypt
-
Research Site
Giza, Egypt
-
Research Site
Luxor, Egypt
-
Research Site
Sohag, Egypt
Conditions
Explore the condition pages connected to this study.